Order Article Reprints

Aktaş BY, Ata EB, Çeşmeci E, Çakır İY, Coşkunpınar M, Tahillioğlu Y, Güner G, Güven DC, Arık Z, Kertmen N, et al. Seven-Year Single-Center Experience of the Efficacy and Safety of Ferric Carboxymaltose in Cancer Patients with Iron-Deficiency Anemia. Current Oncology. 2023; 30(11):9689-9700. https://doi.org/10.3390/curroncol30110703

Aktaş, Burak Yasin, Emine Büşra Ata, Engin Çeşmeci, İbrahim Yahya Çakır, Muharrem Coşkunpınar, Yağmur Tahillioğlu, Gürkan Güner, Deniz Can Güven, Zafer Arık, Neyran Kertmen, and et al. 2023. "Seven-Year Single-Center Experience of the Efficacy and Safety of Ferric Carboxymaltose in Cancer Patients with Iron-Deficiency Anemia" Current Oncology 30, no. 11: 9689-9700. https://doi.org/10.3390/curroncol30110703

Aktaş, B. Y., Ata, E. B., Çeşmeci, E., Çakır, İ. Y., Coşkunpınar, M., Tahillioğlu, Y., Güner, G., Güven, D. C., Arık, Z., Kertmen, N., Dizdar, Ö., Yalçın, Ş., & Aksoy, S. (2023). Seven-Year Single-Center Experience of the Efficacy and Safety of Ferric Carboxymaltose in Cancer Patients with Iron-Deficiency Anemia. Current Oncology, 30(11), 9689-9700. https://doi.org/10.3390/curroncol30110703